| 产品名称： | Talaromyces marneffei (Segretain et al.) Samson et al. |
|---|---|
| 商品货号： | TS151520 |
| Deposited As： | Penicillium marneffei Segretain et al. |
| Strain Designations： | H1140 |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Partial yeast phase at 37C Cell-mediated immunity Experimental infection in athymic mouse |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) ATCC® Medium 336: Potato dextrose agar (PDA) ATCC® Medium 2003: Czapek yeast extract agar |
| Growth Conditions： | Temperature: 30°C Atmosphere: Typical aerobic |
| Name of Depositor： | N Kudeken |
| Special Collection： | NCRR Contract |
| Chain of Custody： | ATCC <-- N Kudeken <-- T. Sirisanthana |
| Isolation： | Blood of AIDS patient, Chiang Mai, Thailand |
| References： | Kudeken N, et al. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34: 371-378, 1996. PubMed: 8971625 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Talaromyces marneffei (Segretain et al.) Samson et al. |
|---|---|
| 商品货号： | TS151520 |
| Deposited As： | Penicillium marneffei Segretain et al. |
| Strain Designations： | H1140 |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Partial yeast phase at 37C Cell-mediated immunity Experimental infection in athymic mouse |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) ATCC® Medium 336: Potato dextrose agar (PDA) ATCC® Medium 2003: Czapek yeast extract agar |
| Growth Conditions： | Temperature: 30°C Atmosphere: Typical aerobic |
| Name of Depositor： | N Kudeken |
| Special Collection： | NCRR Contract |
| Chain of Custody： | ATCC <-- N Kudeken <-- T. Sirisanthana |
| Isolation： | Blood of AIDS patient, Chiang Mai, Thailand |
| References： | Kudeken N, et al. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34: 371-378, 1996. PubMed: 8971625 |
